Proteinase 3 (PR3), also called myeloblastin, is involved in the control of myeloid cell growth, but the underlying molecular mechanisms have not been elucidated. In U937/ PR3, stably transfected with PRCRSV/PR3 to overexpress PR3, PMA-induced p21 expression was significantly decreased as compared with control U937, and this phenomenon was reversed in the presence of the serine proteinase inhibitor, pefabloc. Conversely, when PR3 was inactivated by small interfering RNA, p21 protein was increased, and PMA-induced monocytic differentiation was potentiated. Mass spectrometry analysis identified Ala 45 as the primary cleavage site on p21, and the recombinant mutated p21A45R, generated by site-directed mutagenesis and expressed in Escherichia coli, was resistant to in vitro PR3 cleavage. The U937 cells were then stably transfected with either PRCRSV/p21 or PRCRSV/ p21A45R, to ectopically express wild type p21 or PR3-resistant p21, respectively. In U937/p21A45R treated with PS-341, a selective proteasome inhibitor, a significant decrease in the S phase and a blockade in the G 0 -G 1 phase of cell cycle were observed when compared with U937/p21 or control U937. This suggested that both PR3 and the proteasome are efficiently involved in the proteolytic regulation of p21 expression in myeloid cells. Moreover, PMAinduced p21 expression was more pronounced in U937/ p21A45R compared with U937/p21 and was concomitant with the morphological features of early differentiation. Our data demonstrated that p21 is one specific target of PR3 and that PR3-mediated p21 cleavage prevents monocytic differentiation.
Proteinase 3 (PR3)1 is a neutrophil-derived proteinase originally described in azurophilic granules along with its homologues elastase, cathepsin G, and azurocidin (1-3). Despite the strong homology between PR3 and elastase, PR3 appears to display some functional and structural features of its own (4, 5). Interestingly, PR3 was cloned in HL-60 myeloid cells and was called myeloblastin, because its mRNA was down-regulated during myeloid differentiation (6). PR3 has been involved in the control of proliferation in normal hematopoietic progenitors and in early steps in their transformation. PR3 is overexpressed in myeloid leukemia (7,8). Further studies have shown that PR3 is a granulocyte-macrophage colony-stimulating factor-responsive gene, which can confer serum independence to precursor cells (9). Although several molecular targets have been postulated, such as the transcription factor Sp1 (10) or the 28-kDa heat shock protein (11), no clear demonstration has identified a specific PR3 target involved in the regulation of proliferation. In a model of mast cell lines (RBL and HMC1) stably transfected with either PR3 or elastase or an inactive PR3 mutant PR3S203A, we have provided evidence that PR3, but not elastase or its inactive mutant PR3S203A, had a proliferative activity and that the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 was a molecular target of PR3 (12). p21 belongs to the family of cyclin-dependent kinase in...